Breathe Easy Study

Purpose: to evaluate the safety and tolerability of a potential new drug to treat severe uncontrolled asthma.

This study has 1 screening appointment, 1 inpatient stays of 5 days and 4 nights and 13 outpatient visits.

Participants must have mild to moderate asthma.

Reimbursement for study participation will be provided for time and travel of up to $7,821.

Participants must be comfortable with lung function tests and daily diary entries.

The study drug is administered via subcutaneous shot.  

This study has been reviewed by an Institutional Review Board.

Lab records are not required for eligibility but may help determine if you are qualified for an in person screen. Request records of CBC w/ diff and/or eosinophil count.

Call 612-315-6490 to discuss your eligibility today!